Latest News
March 26, 2025
Altislabs’ AI tool could help drugmakers cut risk in late-stage cancer trials
January 29, 2025
Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways
January 10, 2025
Tempus announces a collaboration with Genialis to develop RNA-based biomarker algorithms
December 12, 2024
Debiopharm Innovation Fund: Leading European Digital Health investor with award-winning portfolio companies